vs

Side-by-side financial comparison of DouYu International Holdings Ltd (DOYU) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $147.1M, roughly 1.8× DouYu International Holdings Ltd).

DouYu International Holdings Ltd operates a leading live streaming platform centered on video game and esports content primarily in mainland China. It offers interactive live streams covering professional esports tournaments, casual gaming content, and variety entertainment, targeting young gaming enthusiasts as its core user base, with main revenue streams including virtual gifting, advertising, and paid memberships.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

DOYU vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.8× larger
HCM
$270.8M
$147.1M
DOYU

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
DOYU
DOYU
HCM
HCM
Revenue
$147.1M
$270.8M
Net Profit
$2.0M
Gross Margin
13.5%
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
Revenue YoY
-16.5%
Net Profit YoY
-83.6%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOYU
DOYU
HCM
HCM
Q4 25
$270.8M
Q2 25
$147.1M
$277.7M
Q1 25
$130.5M
$324.5M
Q2 24
$142.0M
$305.7M
Q1 24
$144.0M
Q2 23
$532.9M
Q2 22
$202.0M
Net Profit
DOYU
DOYU
HCM
HCM
Q4 25
$2.0M
Q2 25
$455.0M
Q1 25
$-11.0M
$11.9M
Q2 24
$-6.8M
$25.8M
Q1 24
$-12.2M
Q2 23
$168.6M
Q2 22
$-162.9M
Gross Margin
DOYU
DOYU
HCM
HCM
Q4 25
37.7%
Q2 25
13.5%
0.1%
Q1 25
12.0%
48.0%
Q2 24
8.2%
41.1%
Q1 24
10.5%
Q2 23
0.0%
Q2 22
0.1%
Operating Margin
DOYU
DOYU
HCM
HCM
Q4 25
-13.2%
Q2 25
-1.3%
Q1 25
-2.8%
-5.0%
Q2 24
-11.6%
-9.0%
Q1 24
-16.1%
Q2 23
21.0%
Q2 22
-97.4%
Net Margin
DOYU
DOYU
HCM
HCM
Q4 25
0.7%
Q2 25
163.8%
Q1 25
-8.4%
3.7%
Q2 24
-4.8%
8.4%
Q1 24
-8.5%
Q2 23
31.6%
Q2 22
-80.6%
EPS (diluted)
DOYU
DOYU
HCM
HCM
Q4 25
$0.00
Q2 25
$0.52
Q1 25
$0.01
Q2 24
$0.03
Q1 24
Q2 23
$0.19
Q2 22
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOYU
DOYU
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$214.4M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$279.9M
$1.2B
Total Assets
$448.1M
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOYU
DOYU
HCM
HCM
Q4 25
$1.4B
Q2 25
$214.4M
$1.4B
Q1 25
$35.2M
$836.1M
Q2 24
$558.8M
$802.5M
Q1 24
$70.7M
Q2 23
$856.2M
Q2 22
$826.2M
Total Debt
DOYU
DOYU
HCM
HCM
Q4 25
$93.2M
Q2 25
$93.4M
Q1 25
$82.8M
Q2 24
$82.1M
Q1 24
Q2 23
$40.1M
Q2 22
$418.0K
Stockholders' Equity
DOYU
DOYU
HCM
HCM
Q4 25
$1.2B
Q2 25
$279.9M
$1.2B
Q1 25
$37.4M
$759.9M
Q2 24
$895.6M
$740.1M
Q1 24
$126.4M
Q2 23
$782.0M
Q2 22
$799.7M
Total Assets
DOYU
DOYU
HCM
HCM
Q4 25
$1.8B
Q2 25
$448.1M
$1.8B
Q1 25
$60.8M
$1.3B
Q2 24
$1.1B
$1.3B
Q1 24
$156.2M
Q2 23
$1.3B
Q2 22
$1.2B
Debt / Equity
DOYU
DOYU
HCM
HCM
Q4 25
0.08×
Q2 25
0.08×
Q1 25
0.11×
Q2 24
0.11×
Q1 24
Q2 23
0.05×
Q2 22
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOYU
DOYU
HCM
HCM
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOYU
DOYU
HCM
HCM
Q4 25
$8.2M
Q2 25
$-72.9M
Q1 25
$40.3M
Q2 24
$-39.8M
Q1 24
Q2 23
$226.4M
Q2 22
$-89.9M
Free Cash Flow
DOYU
DOYU
HCM
HCM
Q4 25
$3.4M
Q2 25
$-82.2M
Q1 25
$32.5M
Q2 24
$-49.9M
Q1 24
Q2 23
$202.0M
Q2 22
$-105.6M
FCF Margin
DOYU
DOYU
HCM
HCM
Q4 25
1.2%
Q2 25
-29.6%
Q1 25
10.0%
Q2 24
-16.3%
Q1 24
Q2 23
37.9%
Q2 22
-52.3%
Capex Intensity
DOYU
DOYU
HCM
HCM
Q4 25
1.8%
Q2 25
3.3%
Q1 25
2.4%
Q2 24
3.3%
Q1 24
Q2 23
4.6%
Q2 22
7.8%
Cash Conversion
DOYU
DOYU
HCM
HCM
Q4 25
4.21×
Q2 25
-0.16×
Q1 25
3.38×
Q2 24
-1.54×
Q1 24
Q2 23
1.34×
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons